For many people living with kidney failure, dialysis is a vital and life-sustaining treatment. However, it can also come with challenging side effects including fatigue, drops in blood pressure, headaches and a general feeling of being unwell after sessions. Over time, these effects can take a real toll on both physical health and emotional wellbeing.
A new research study in Manchester is exploring whether a medical device could help reduce some of these dialysis side effects, with the aim of making treatment more tolerable for patients.
What is this dialysis side effects study about?
The study, led by a research team at the NIHR Manchester Clinical Research Facility, is testing a device designed to help stabilise patients during dialysis. The device is intended to reduce the physical stress that dialysis can place on the body, particularly on the heart and circulation.
The researchers have now recruited the first patient into the study, marking an important early milestone. By carefully monitoring how patients respond, the team hopes to learn whether the device can safely reduce common dialysis-related symptoms.
You can read the full original article from Manchester Royal Infirmary here: Research team at NIHR Manchester CRF recruits first patient to device study to help reduce side effects from dialysis treatment.
Why this matters for kidney patients
While dialysis saves lives, many patients describe it as exhausting and disruptive to daily life. Side effects can make it harder to recover between sessions, limit independence, and affect quality of life. People living with dialysis often navigate fatigue, blood pressure changes, and other challenges that extend beyond the treatment itself.
Research that focuses on improving the dialysis experience, not just keeping people alive, is particularly important. Even small improvements in how patients feel during and after treatment can make a meaningful difference to daily life. For people in Greater Manchester and the North West, the fact that this research is being conducted at Manchester Royal Infirmary means that local patients may eventually benefit directly.
What should patients know now?
This study is still at an early stage. The device is being carefully tested to understand whether it is safe and effective, and it is not yet part of standard dialysis care. It may take time before researchers know whether it could be used more widely. If you have questions about your own dialysis care and any symptoms you experience, your renal team remains the best source of advice.
However, studies like this reflect a growing recognition that patient comfort, wellbeing and long-term health matter just as much as clinical outcomes. At MRIKPA, we continue to follow research that aims to improve everyday experiences for people living with kidney disease, and we share updates to help patients and families stay informed.
Do not hesitate to get in touch with our volunteers if this article has prompted questions about your own care or treatment options. We are here to listen. Email support@mrikpa.org.uk or call 07745 242 684.
This article is provided for general information and awareness purposes only and was believed to be accurate at the time of publishing. It is not intended as medical advice — please always consult your doctor or renal team for guidance on your individual circumstances. Images used are for illustration purposes only and may not be medically or editorially accurate. While we take every care, errors can occur. If you spot an inaccuracy, please let us know at support@mrikpa.org.uk.
